Structure of human factor VIIa and its implications for the triggering of blood coagulation.
暂无分享,去创建一个
A M Brzozowski | O. Olsen | A. Brzozowski | A. Pike | A. Pike | S. Roberts | E. Persson | S. M. Roberts | S M Roberts | E Persson | O H Olsen | A C Pike
[1] W. Ruf,et al. Active Site Modification of Factor VIIa Affects Interactions of the Protease Domain with Tissue Factor* , 1997, The Journal of Biological Chemistry.
[2] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[3] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[4] W. Ruf,et al. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[5] P. Hogg,et al. Effects of Ca2+ binding on the protease module of factor Xa and its interaction with factor Va. Evidence for two Gla-independent Ca(2+)-binding sites in factor Xa. , 1993, Journal of Biological Chemistry.
[6] P. Neuenschwander,et al. The Location of the Active Site of Blood Coagulation Factor VIIa above the Membrane Surface and Its Reorientation upon Association with Tissue Factor , 1996, The Journal of Biological Chemistry.
[7] R. Huber,et al. The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and of its ternary complex with Ile-Val at 1.9 A resolution. , 1978, Journal of molecular biology.
[8] S Foundling,et al. The 2.8 A crystal structure of Gla‐domainless activated protein C. , 1996, The EMBO journal.
[9] K Fujikawa,et al. The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.
[10] David W. Banner,et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor , 1996, Nature.
[11] G. Gippert,et al. Solution structure of the N-terminal EGF-like domain from human factor VII. , 1998, Biochemistry.
[12] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[13] O. Olsen,et al. Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy , 1996, Protein science : a publication of the Protein Society.
[14] P. Freskgård,et al. Incorporation of an Active Site Inhibitor in Factor VIIa Alters the Affinity for Tissue Factor* , 1997, The Journal of Biological Chemistry.
[15] R. St Charles,et al. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant. , 1999, Journal of molecular biology.
[16] R. Kelley,et al. Analysis of the factor VIIa binding site on human tissue factor: effects of tissue factor mutations on the kinetics and thermodynamics of binding. , 1995, Biochemistry.
[17] W. Ruf,et al. Allosteric regulation of the cofactor-dependent serine protease coagulation factor VIIa. , 1998, Trends in cardiovascular medicine.
[18] S. Iwanaga,et al. Conformation of Factor VIIa Stabilized by a Labile Disulfide Bond (Cys-310–Cys-329) in the Protease Domain Is Essential for Interaction with Tissue Factor* , 1997, The Journal of Biological Chemistry.
[19] J. Schullek,et al. Energetic contributions and topographical organization of ligand binding residues of tissue factor. , 1995, Biochemistry.
[20] L. Poulsen,et al. Signal Transduction via the Mitogen-activated Protein Kinase Pathway Induced by Binding of Coagulation Factor VIIa to Tissue Factor* , 1998, The Journal of Biological Chemistry.
[21] R. Huber,et al. Structure of human des(1-45) factor Xa at 2.2 A resolution. , 1993, Journal of molecular biology.
[22] A. R. Khan,et al. Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes , 1998, Protein science : a publication of the Protein Society.
[23] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[24] Robert Huber,et al. X-ray Structure of Active Site-inhibited Clotting Factor Xa , 1996, The Journal of Biological Chemistry.
[25] D. Turk,et al. The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationships , 1992, Protein science : a publication of the Protein Society.
[26] B. Furie,et al. The molecular basis of blood coagulation , 1988, Cell.
[27] R. Huber,et al. Structural basis of the activation and action of trypsin , 1978 .
[28] S. Iwanaga,et al. Identification of regions of bovine factor VII essential for binding to tissue factor. , 1994, The Journal of biological chemistry.
[29] S. Iwanaga,et al. Molecular Mechanism of Tissue Factor-mediated Acceleration of Factor VIIa Activity* , 1996, The Journal of Biological Chemistry.
[30] W. Ruf,et al. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. , 1998, The Journal of clinical investigation.
[31] H Brandstetter,et al. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[32] Sung-Hou Kim,et al. Structural basis for chemical inhibition of human blood coagulation factor Xa. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] E. Persson. Characterization of the interaction between the light chain of factor VIIa and tissue factor , 1997, FEBS letters.
[34] Axel T. Brunger,et al. X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .